Bluestone Pharma
Michael Faber is the Managing Partner at Bluestone Pharma, a company specializing in oral probiotics for ENT infections, fresh breath, and dental/oral health. With previous experience as the World Area Business Manager at Stratum Nutrition and Head of Business Development at analyze & realize ag, Michael has expertise in sales, distribution, and seeking business opportunities in the health ingredients industry. Additionally, Michael served as the Vice President at Frutarom USA Inc and holds a BS in economics from Fachhochschule Hildesheim/Holzminden/Göttingen.
This person is not in any teams
This person is not in any offices
Bluestone Pharma
Bluestone Pharma® is a Swiss healthcare company and a Pioneer in the field of Medical Probiotics. Our main purpose is to research and produce innovative, unique and highly effective Finished Probiotic Formulas, providing our partners an exclusive solution to target patient’s unmet needs and drive industry progress together. We guarantee product investments to our partners through IP-protected supply chains on the active compound level and the finished dose form. Additionally, we provide a competitive advantage through probiotics with clinically proven health benefits and proprietary technology. Bactoblis®, our flagship probiotic formula, stands as the world's most clinically tested probiotic for recurrent respiratory infections in children and teenagers, supported by over 30 conducted clinical studies. Since our founding in 2013, our products have expanded into 25 countries, and healthcare professionals have prescribed more than 200 million doses.